Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MLC901 for Moderate to Severe Traumatic Brain Injury
NCT04487275Phase 4Unknown
- Start
- Aug 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in traumatic brain injury (TBI) comparing MLC901 Arm with Placebo Arm (2 arms). Primary endpoints: Modified Rankin Scale at 6 months and Glasgow Outcome Scale at 6 months. Status: unknown.
02
Drugs
mlc901
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT04487275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04487275.